Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:2233747rdf:typepubmed:Citationlld:pubmed
pubmed-article:2233747lifeskim:mentionsumls-concept:C0035696lld:lifeskim
pubmed-article:2233747lifeskim:mentionsumls-concept:C0021665lld:lifeskim
pubmed-article:2233747lifeskim:mentionsumls-concept:C0002345lld:lifeskim
pubmed-article:2233747lifeskim:mentionsumls-concept:C0679058lld:lifeskim
pubmed-article:2233747lifeskim:mentionsumls-concept:C0301817lld:lifeskim
pubmed-article:2233747lifeskim:mentionsumls-concept:C1533691lld:lifeskim
pubmed-article:2233747lifeskim:mentionsumls-concept:C1547699lld:lifeskim
pubmed-article:2233747lifeskim:mentionsumls-concept:C2700640lld:lifeskim
pubmed-article:2233747pubmed:issue6lld:pubmed
pubmed-article:2233747pubmed:dateCreated1990-12-7lld:pubmed
pubmed-article:2233747pubmed:abstractTextRat insulin-like growth factor-I (IGF-I) cDNA sequences predict two prohormones that differ in the carboxy-terminal extension peptide (E-peptide) as a result of the inclusion or exclusion of the 52-basepair exon 4 sequence. In the absence of exon 4, the sequence codes for the IGF-Ia prohormone, whose E region contains two potential N-glycosylation sites. With differential splicing and the inclusion of exon 4, the resultant mRNA codes for IGF-Ib, with a longer E-region sequence. In addition, as a consequence of a frame shift, both potential glycosylation sites are lost in the IGF-Ib peptide. We used an in vitro translation system supplemented with canine pancreatic microsomal membranes to analyze cotranslational processing of the IGF-I propeptides. We have demonstrated that IGF-Ia prohormone, which contains two potential N-glycosylation sites in the E region, can be N-glycosylated in vitro, and that both glycosylation sites are probably used. As expected, the IGF-Ib preprohormone is processed by microsomes, but is not glycosylated.lld:pubmed
pubmed-article:2233747pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2233747pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2233747pubmed:languageenglld:pubmed
pubmed-article:2233747pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2233747pubmed:citationSubsetIMlld:pubmed
pubmed-article:2233747pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2233747pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2233747pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2233747pubmed:statusMEDLINElld:pubmed
pubmed-article:2233747pubmed:monthJunlld:pubmed
pubmed-article:2233747pubmed:issn0888-8809lld:pubmed
pubmed-article:2233747pubmed:authorpubmed-author:LeRoithDDlld:pubmed
pubmed-article:2233747pubmed:authorpubmed-author:BachM AMAlld:pubmed
pubmed-article:2233747pubmed:authorpubmed-author:RobertsC...lld:pubmed
pubmed-article:2233747pubmed:authorpubmed-author:SmithE PEPlld:pubmed
pubmed-article:2233747pubmed:issnTypePrintlld:pubmed
pubmed-article:2233747pubmed:volume4lld:pubmed
pubmed-article:2233747pubmed:ownerNLMlld:pubmed
pubmed-article:2233747pubmed:authorsCompleteYlld:pubmed
pubmed-article:2233747pubmed:pagination899-904lld:pubmed
pubmed-article:2233747pubmed:dateRevised2007-11-14lld:pubmed
pubmed-article:2233747pubmed:meshHeadingpubmed-meshheading:2233747-...lld:pubmed
pubmed-article:2233747pubmed:meshHeadingpubmed-meshheading:2233747-...lld:pubmed
pubmed-article:2233747pubmed:meshHeadingpubmed-meshheading:2233747-...lld:pubmed
pubmed-article:2233747pubmed:meshHeadingpubmed-meshheading:2233747-...lld:pubmed
pubmed-article:2233747pubmed:meshHeadingpubmed-meshheading:2233747-...lld:pubmed
pubmed-article:2233747pubmed:meshHeadingpubmed-meshheading:2233747-...lld:pubmed
pubmed-article:2233747pubmed:meshHeadingpubmed-meshheading:2233747-...lld:pubmed
pubmed-article:2233747pubmed:meshHeadingpubmed-meshheading:2233747-...lld:pubmed
pubmed-article:2233747pubmed:meshHeadingpubmed-meshheading:2233747-...lld:pubmed
pubmed-article:2233747pubmed:meshHeadingpubmed-meshheading:2233747-...lld:pubmed
pubmed-article:2233747pubmed:year1990lld:pubmed
pubmed-article:2233747pubmed:articleTitleAlternative splicing produces messenger RNAs encoding insulin-like growth factor-I prohormones that are differentially glycosylated in vitro.lld:pubmed
pubmed-article:2233747pubmed:affiliationDiabetes Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland 20892.lld:pubmed
pubmed-article:2233747pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:2233747pubmed:publicationTypeResearch Support, U.S. Gov't, P.H.S.lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2233747lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2233747lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2233747lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2233747lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2233747lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2233747lld:pubmed